Junli He bought $394k of HRGN
CEO at Harvard Apparatus Regenerative Technology, Inc.. 368,630 shares at an average of $1.07, traded Sep 11, 2026, filed Sep 25, 2026.
Score components
- +25RoleCEO
- +16Trade size$394k at market
- +6Relative to holdingsHoldings up 38%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-031181, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | CConversion Common Stock | +683,725 | $1.05 | $718k | 964,300 | 18 d ago |
| Sep 11, 2026 | POpen-market purchase Common Stock | +361,905 | $1.05 | $380k | 1,326,205 | 18 d ago |
| Sep 15, 2026 | POpen-market purchase Common Stock | +6,725 | $2.15 | $14k | 1,332,930 | 18 d ago |
| Sep 11, 2026 | CConversion Bridge Note (04/14/2026)derivative | -310,000 | - | - | 0 | 18 d ago |
| Sep 11, 2026 | CConversion Bridge Note (05/13/2026)derivative | -205,378 | - | - | 0 | 18 d ago |
| Sep 11, 2026 | CConversion Bridge Note (07/16/2026)derivative | -202,533 | - | - | 0 | 18 d ago |
Related signals
Other insiders at Harvard Apparatus Regenerative Technology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $5,100 3,000 shares | +1% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $594 300 shares | +0% | |
| 38Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $21k 11,225 shares | +4% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $6,966 4,050 shares | +2% | |
| 20Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $6,598 2,299 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.